Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 1b Open Label Positron Emission Tomography Study to Assess Changes in Abdominal [11C]AZ14132516 Uptake Following Administration of Single and Repeat Doses of AZD7798 to Healthy Participants and Patients With Crohn's Disease

NCT06053424 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT06053424
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06053424 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 1b Open Label Positron Emission Tomography Study to Assess Changes in Abdominal [11C]AZ14132516 Uptake Following Administration of Single and Repeat Doses of AZD7798 to Healthy Participants and Patients With Crohn's Disease
Lead sponsor
AstraZeneca
Phase
Phase 1
Overall status
Completed
Start date
September 25, 2023
Completion date
October 8, 2024
Enrollment
13 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

crohn's disease